跳至主要内容
临床试验/EUCTR2016-004157-33-IT
EUCTR2016-004157-33-IT进行中(未招募)1 期

Effect of the administration of 75 mg of acetylsalicylic acid + 200mg of triglycerides of n-3 series fatty acids (omega 3 + ASA) on the biosynthesis of platelet thromboxane A2 in patients with cardiovascular disease. - NASA (n-3 and ASA in patients with Stable Angina)

CENTRO CARDIOLOGICO SPA FONDAZIONE MONZINO0 个研究点目标入组 24 人开始时间: 2021年6月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patients with stable coronary heart disease, aged between 18 and 80 years, already treatrd with ASA 100 mg for at least one month.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 14
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 10

排除标准

  • The exclusion criteria are: a percutaneous angioplasty or acute coronary syndrome in the month prior to randomization; treatment with inhibitors of glycoprotein IIb / IIIa or thrombolytics agents in the month prior to randomization; concomitant treatment with products containing fatty acids of the n-3 series; concomitant treatment with ibuprofen, naproxen, or warfarin; thrombocytopenia (platelet count =100x103 cells / mm3); anemia (hemoglobin =10 g / dl); renal impairment (creatinine 2.5 mg / dl).

研究者

发起方
CENTRO CARDIOLOGICO SPA FONDAZIONE MONZINO

相似试验